These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 23272129)

  • 41. A BMP7 Variant Inhibits Tumor Angiogenesis In Vitro and In Vivo through Direct Modulation of Endothelial Cell Biology.
    Tate CM; Mc Entire J; Pallini R; Vakana E; Wyss L; Blosser W; Ricci-Vitiani L; D'Alessandris QG; Morgante L; Giannetti S; Larocca LM; Todaro M; Benfante A; Colorito ML; Stassi G; De Maria R; Rowlinson S; Stancato L
    PLoS One; 2015; 10(4):e0125697. PubMed ID: 25919028
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular isolation and characterization of a soluble isoform of activated leukocyte cell adhesion molecule that modulates endothelial cell function.
    Ikeda K; Quertermous T
    J Biol Chem; 2004 Dec; 279(53):55315-23. PubMed ID: 15496415
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of gastrin-induced proangiogenic effects in vivo in orthotopic U373 experimental human glioblastomas and in vitro in human umbilical vein endothelial cells.
    Lefranc F; Mijatovic T; Mathieu V; Rorive S; Decaestecker C; Debeir O; Brotchi J; Van Ham P; Salmon I; Kiss R
    Clin Cancer Res; 2004 Dec; 10(24):8250-65. PubMed ID: 15623601
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of adrenomedullin on endothelial cells in the multistep process of angiogenesis: involvement of CRLR/RAMP2 and CRLR/RAMP3 receptors.
    Fernandez-Sauze S; Delfino C; Mabrouk K; Dussert C; Chinot O; Martin PM; Grisoli F; Ouafik L; Boudouresque F
    Int J Cancer; 2004 Mar; 108(6):797-804. PubMed ID: 14712479
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Targeting tumor angiogenesis with histone deacetylase inhibitors: the hydroxamic acid derivative LBH589.
    Qian DZ; Kato Y; Shabbeer S; Wei Y; Verheul HM; Salumbides B; Sanni T; Atadja P; Pili R
    Clin Cancer Res; 2006 Jan; 12(2):634-42. PubMed ID: 16428510
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Telomerase mediates vascular endothelial growth factor-dependent responsiveness in a rat model of hind limb ischemia.
    Zaccagnini G; Gaetano C; Della Pietra L; Nanni S; Grasselli A; Mangoni A; Benvenuto R; Fabrizi M; Truffa S; Germani A; Moretti F; Pontecorvi A; Sacchi A; Bacchetti S; Capogrossi MC; Farsetti A
    J Biol Chem; 2005 Apr; 280(15):14790-8. PubMed ID: 15687494
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of auriculasin on vascular endothelial growth factor (VEGF)-induced angiogenesis via regulation of VEGF receptor 2 signaling pathways in vitro and in vivo.
    Cho HD; Moon KD; Park KH; Lee YS; Seo KI
    Food Chem Toxicol; 2018 Nov; 121():612-621. PubMed ID: 30236598
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Barbigerone, an isoflavone, inhibits tumor angiogenesis and human non-small-cell lung cancer xenografts growth through VEGFR2 signaling pathways.
    Li X; Wang X; Ye H; Peng A; Chen L
    Cancer Chemother Pharmacol; 2012 Sep; 70(3):425-37. PubMed ID: 22814678
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CD93 interacts with the PDZ domain-containing adaptor protein GIPC: implications in the modulation of phagocytosis.
    Bohlson SS; Zhang M; Ortiz CE; Tenner AJ
    J Leukoc Biol; 2005 Jan; 77(1):80-9. PubMed ID: 15459234
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regulation of angiogenesis by histone chaperone HIRA-mediated incorporation of lysine 56-acetylated histone H3.3 at chromatin domains of endothelial genes.
    Dutta D; Ray S; Home P; Saha B; Wang S; Sheibani N; Tawfik O; Cheng N; Paul S
    J Biol Chem; 2010 Dec; 285(53):41567-77. PubMed ID: 21041298
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Betacellulin induces angiogenesis through activation of mitogen-activated protein kinase and phosphatidylinositol 3'-kinase in endothelial cell.
    Kim HS; Shin HS; Kwak HJ; Cho CH; Lee CO; Koh GY
    FASEB J; 2003 Feb; 17(2):318-20. PubMed ID: 12475887
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Soluble melanoma cell adhesion molecule (sMCAM/sCD146) promotes angiogenic effects on endothelial progenitor cells through angiomotin.
    Stalin J; Harhouri K; Hubert L; Subrini C; Lafitte D; Lissitzky JC; Elganfoud N; Robert S; Foucault-Bertaud A; Kaspi E; Sabatier F; Aurrand-Lions M; Bardin N; Holmgren L; Dignat-George F; Blot-Chabaud M
    J Biol Chem; 2013 Mar; 288(13):8991-9000. PubMed ID: 23389031
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A novel vasculo-angiogenic effect of cilostazol mediated by cross-talk between multiple signalling pathways including the ERK/p38 MAPK signalling transduction cascade.
    Chao TH; Tseng SY; Li YH; Liu PY; Cho CL; Shi GY; Wu HL; Chen JH
    Clin Sci (Lond); 2012 Aug; 123(3):147-59. PubMed ID: 22339730
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anti-angiogenic action of the C-terminal domain of tenomodulin that shares homology with chondromodulin-I.
    Oshima Y; Sato K; Tashiro F; Miyazaki J; Nishida K; Hiraki Y; Tano Y; Shukunami C
    J Cell Sci; 2004 Jun; 117(Pt 13):2731-44. PubMed ID: 15150318
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HB-EGF promotes angiogenesis in endothelial cells via PI3-kinase and MAPK signaling pathways.
    Mehta VB; Besner GE
    Growth Factors; 2007 Aug; 25(4):253-63. PubMed ID: 18092233
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis.
    Lovren F; Pan Y; Shukla PC; Quan A; Teoh H; Szmitko PE; Peterson MD; Gupta M; Al-Omran M; Verma S
    Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1440-9. PubMed ID: 19351806
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Glucocorticoid-mediated inhibition of angiogenic changes in human endothelial cells is not caused by reductions in cell proliferation or migration.
    Logie JJ; Ali S; Marshall KM; Heck MM; Walker BR; Hadoke PW
    PLoS One; 2010 Dec; 5(12):e14476. PubMed ID: 21217824
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Requirement of the nuclear localization of transcription enhancer factor 3 for proliferation, migration, tube formation, and angiogenesis induced by vascular endothelial growth factor.
    Liu X; Zhao D; James L; Li J; Zeng H
    FASEB J; 2011 Apr; 25(4):1188-97. PubMed ID: 21169383
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A novel CD93 polymorphism in non-obese diabetic (NOD) and NZB/W F1 mice is linked to a CD4+ iNKT cell deficient state.
    Zekavat G; Mozaffari R; Arias VJ; Rostami SY; Badkerhanian A; Tenner AJ; Nichols KE; Naji A; Noorchashm H
    Immunogenetics; 2010 Jun; 62(6):397-407. PubMed ID: 20387063
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity. EGF-receptor inhibition may prevent tumor cell dissemination.
    Festuccia C; Angelucci A; Gravina GL; Biordi L; Millimaggi D; Muzi P; Vicentini C; Bologna M
    Thromb Haemost; 2005 May; 93(5):964-75. PubMed ID: 15886816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.